 MALVERN, Pa., April 29, 2021 GLOBE NEWSWIRE -- TELA Bio, Inc. TELA, a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the company will report first quarter ended March 31, 2021, financial results on Thursday, May 13, 2021. TELA Bios management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. 